Multiple GWA studies of prostate cancer conducted in European White populations are ongoing. These studies will continue to have a dramatic impact on our understanding of the contribution of common ge
Prostate cancer, a leading cause of cancer death, displays a broad range of clinical behavior from relatively indolent to aggressive metastatic disease. To explore potential molecular variation underl
The cohort consists of 900 individuals with prostate cancer who came to an oncology center in southern Sweden for therapy. The collection of this study started in 2007 and is ongoing. A control group
